These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
724 related items for PubMed ID: 16966022
21. Resistant cases of psoriatic arthritis: how to manage them. Atzeni F, Sarzi-Puttini P, Vena GA. J Rheumatol Suppl; 2009 Aug; 83():73-5. PubMed ID: 19661549 [Abstract] [Full Text] [Related]
22. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis. Chan CY, Browning JC, Larsen F, Hsu S. Dermatol Online J; 2008 Sep 15; 14(9):12. PubMed ID: 19061594 [Abstract] [Full Text] [Related]
23. [New therapeutic strategy of rheumatoid arthritis to reach the goal of suppression of joint destruction]. Yamaguchi Y, Yamamoto K. Clin Calcium; 2007 Apr 15; 17(4):463-73. PubMed ID: 17404474 [Abstract] [Full Text] [Related]
26. Circulating chromogranin A reveals extra-articular involvement in patients with rheumatoid arthritis and curbs TNF-alpha-elicited endothelial activation. Di Comite G, Rossi CM, Marinosci A, Lolmede K, Baldissera E, Aiello P, Mueller RB, Herrmann M, Voll RE, Rovere-Querini P, Sabbadini MG, Corti A, Manfredi AA. J Leukoc Biol; 2009 Jan 15; 85(1):81-7. PubMed ID: 18832606 [Abstract] [Full Text] [Related]
29. Reversal of multifocal cutaneous lymphoproliferative disease associated with Epstein-Barr virus after withdrawal of methotrexate therapy for rheumatoid arthritis. Maruani A, Wierzbicka E, Machet MC, Abdallah-Lotf M, de Muret A, Machet L. J Am Acad Dermatol; 2007 Nov 15; 57(5 Suppl):S69-71. PubMed ID: 17938029 [Abstract] [Full Text] [Related]
30. Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor. Rioja I, Hughes FJ, Sharp CH, Warnock LC, Montgomery DS, Akil M, Wilson AG, Binks MH, Dickson MC. Arthritis Rheum; 2008 Aug 15; 58(8):2257-67. PubMed ID: 18668547 [Abstract] [Full Text] [Related]
31. Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs. Avouac J, Allanore Y. Expert Opin Pharmacother; 2008 May 15; 9(7):1121-8. PubMed ID: 18422470 [Abstract] [Full Text] [Related]
32. Review of medications used in juvenile rheumatoid arthritis. Guthrie B, Rouster-Stevens KA, Reynolds SL. Pediatr Emerg Care; 2007 Jan 15; 23(1):38-46. PubMed ID: 17228221 [Abstract] [Full Text] [Related]
34. MonitorNet: the Italian multi-centre observational study aimed at estimating the risk/benefit profile of biologic agents in real-world rheumatology practice. Sfriso P, Salaffi F, Montecucco CM, Bombardieri S, Todesco S. Reumatismo; 2009 Jan 15; 61(2):132-9. PubMed ID: 19633800 [Abstract] [Full Text] [Related]